In humans, genetic deficiency of AID leads to Type-2 Hyper-IgM Syndrome (HIGM2), an immunodeficiency characterized by the absence of antibodies other than the IgM class (Revy et al., 2000). The gene discussed is AICDA; the disease is immunodeficiency disease.